Table 3.

Status of liposomal formulations in clinical trial for brain drug delivery

Compounds (trade name)	Therapeutic use	Status	References
Doxorubicin (Doxil®)	Glioblastoma multiformae	Phase II	Beier et al., 2009; Ananda et al., 2011
	Pediatric brain tumor	Phase II
Daunorubicin (Daunoxome®)	Pediatric brain tumor	Phase I	Lippens, 1999
Doxorubicin (Myocet®)	Glioblastoma multiformae	Phase II	Ananda et al., 2011
Cytarabine (Depocyt®)	Lymphomatus meningitis	FDA approved	Benesch and Urban, 2008
Amphotericin B (AmBisome®)	Cryptococcal meningitis	FDA approved	Loyse et al., 2013
Amphotericin B (Abelcet®)	Cryptococcal menigitis	FDA approved	Loyse et al., 2013